Compare Kalbe Farma Tbk (KLBF) vs Reksa Dana Indeks Batavia IDX30 ETF (XBID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs Reksa Dana Indeks Batavia IDX30 ETF — how do they compare? Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume), while Reksa Dana Indeks Batavia IDX30 ETF trades at Rp454 (market cap 15.98B, 12.1K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 2343.6× Reksa Dana Indeks Batavia IDX30 ETF's market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 12.1K). Which is the better fit depends on your goals.
| KLBF | XBID | |
|---|---|---|
Market Cap | 37.45T | 15.98B |
Volume | 41.79M | 12.1K |
Lot | 417.89K | 121 |
Turnover | 33.46B | 6.85M |
Average Price | 800.79 | 566.2 |
Value | 33.46B | 6.85M |
Indicative Equilibrium Price | 800 | — |
Indicative Equilibrium Volume | 18.3K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →
